HOTAIRM1 and hepatocellular carcinoma: To further validate the HOTAIRM1 effect on lenvatinib sensitivity was dependent on the activation of autophagy, our in vivo study demonstrated that downregulation of HOTAIRM1 combined with an autophagy inhibitor can markedly improve the efficacy of lenvatinib therapy in lenvatinib-resistant HCC.